查看购物车
  • Traditional Chinese
  • English
  • Japanese
  • Korean
亚太地区器官移植诊断市场：分析与预测（2023-2033）
市场调查报告书
商品编码
1439029

亚太地区器官移植诊断市场：分析与预测（2023-2033）

Asia-Pacific Organ Transplant Diagnostics Market: Analysis and Forecast, 2023-2033
出版日期: | 出版商: BIS Research | 英文 71 Pages | 商品交期: 1-5个工作天内

价格
主要市场统计数据
预测期 2023-2033
2023年评估价值 12.5亿美元
2033年预测 34.5亿美元
复合年增长率 10.73%

2023年亚太地区器官移植诊断市场规模达12.5亿美元。

预计到 2033 年，市场规模将达到 34.5 亿美元，2023-2033 年预测期间复合年增长率为 10.73%。导致器官衰竭的慢性疾病增加，移植诊断的使用扩大，干细胞疗法的采用扩大，由于白血病患者数量的增加对移植诊断测试的需求增加，移植领域分子和基因组技术的进步带来的好处诊断和报销系统许多关键因素正在推动该行业的发展，包括有利的法规环境的存在。

在多种因素的推动下，亚太地区器官移植诊断市场正在经历显着成长。这包括导致器官衰竭的慢性疾病盛行率增加、移植诊断的使用增加以及该地区对干细胞治疗的接受度增加。此外，白血病等疾病的日益普及正在推动对移植诊断测试的需求。该领域也受益于提高诊断能力的分子和基因组技术的进步。此外，报销计划等有利的监管条件进一步刺激了市场成长。为了满足器官移植有效诊断解决方案日益增长的需求，亚太地区器官移植诊断市场将显着扩张。

本报告探讨了亚太地区器官移植诊断市场，概述了市场、国家趋势以及进入市场的公司概况。

目录

执行摘要

第一章 市场范围

第二章调查方法

第三章器官移植诊断市场：概述

  • 目前的市场状况
  • 市场足迹
  • COVID-19 对市场的影响

第四章器官移植诊断市场：产业分析

  • 概述
  • 亚太地区的法律要求与框架
    • 中国
    • 日本
  • 赎回场景
  • 专利分析

第五章器官移植诊断市场：市场动态

  • 影响分析
  • 市场驱动力
  • 市场限制
  • 市场机会

第六章 区域

  • 亚太地区
    • 亚太地区器官移植试验数量（依移植类型）
    • 市场规模及预测

第七章 公司简介

Product Code: BHP1874SS

The Asia-Pacific Organ Transplant Diagnostics Market Expected to Reach $3.45 Billion by 2033

Introduction to Asia-Pacific Organ Transplant Diagnostics Market

KEY MARKET STATISTICS
Forecast Period2023 - 2033
2023 Evaluation$1.25 Billion
2033 Forecast$3.45 Billion
CAGR10.73%

In 2023, the Asia-Pacific organ transplant diagnostics market was valued at $1.25 billion and is expected to reach $3.45 billion by 2033, with a CAGR of 10.73% during the forecast period 2023-2033. Numerous pivotal factors are driving growth in this industry, comprising a rise in chronic diseases leading to organ failure, increased utilization of transplant diagnostics, growing adoption of stem cell therapy, heightened demand for transplant diagnostic tests due to an uptick in leukemia cases, advantages stemming from advancements in molecular and genomic technologies in the transplant diagnostics realm, and the presence of favorable regulatory environments, including reimbursement schemes.

Market Introduction

The Asia-Pacific (APAC) organ transplant diagnostics market is experiencing significant growth, propelled by various factors. This includes the escalating incidence of chronic diseases leading to organ failure, the expanding utilization of transplant diagnostics, and a rising acceptance of stem cell therapy in the region. Additionally, the increasing prevalence of conditions like leukemia is driving demand for transplant diagnostic tests. The sector also benefits from advancements in molecular and genomic technologies, enhancing diagnostic capabilities. Furthermore, favorable regulatory conditions, such as reimbursement schemes, further stimulate market growth. With these dynamics at play, the APAC organ transplant diagnostics market is poised for notable expansion, catering to the growing demand for effective diagnostic solutions in organ transplantation procedures across the region.

Market Segmentation:

Segmentation 1: by Country

  • China
  • Japan
  • India
  • Australia
  • South Korea
  • Singapore
  • Rest-of-Asia-Pacific

How can this report add value to an organization?

Growth/Marketing Strategy: The APAC organ transplant diagnostics market has witnessed major development by key players operating in the market, such as product launches, business expansions, partnerships, collaborations, mergers and acquisitions, funding activities, and regulatory and legal approvals. The favored strategy for the companies has been synergistic activities such as partnerships, collaborations, expansions, and funding activities.

Competitive Strategy: The key players in the APAC organ transplant diagnostics market analyzed and profiled in the study involve established and emerging players that offer different products and services for organ transplant diagnostics. Moreover, a detailed competitive benchmarking of the players operating in the APAC organ transplant diagnostics market has been done to help the reader understand the ways in which players stack against each other, presenting a clear market landscape. Moreover, comprehensive competitive strategies such as partnerships, agreements, collaborations, and mergers and acquisitions will help the reader understand the untapped revenue pockets in the market.

Table of Contents

Executive Summary

1 Market Scope

  • 1.1 Key Questions Answered in the Report:

2 Research Methodology

  • 2.1 Organ Transplant Diagnostics Market: Research Methodology
  • 2.2 Data Sources
    • 2.2.1 Primary Data Sources
    • 2.2.2 Secondary Data Sources
  • 2.3 Market Estimation Model
  • 2.4 Criteria for Company Profiling

3 Organ Transplant Diagnostics Market: Overview

  • 3.1 Current Market Scenario
    • 3.1.1 For Researchers
    • 3.1.2 For Diagnostics
  • 3.2 Market Footprint
  • 3.3 COVID-19 Impact on Market
    • 3.3.1 Impact on Operations
    • 3.3.2 COVID-19 Impact: Current Scenario of Market
    • 3.3.3 Pre- and Post-COVID-19 Impact Assessment
      • 3.3.3.1 Pre-COVID-19 Phase
      • 3.3.3.2 Post-COVID-19 Phase

4 Organ Transplant Diagnostics Market: Industry Analysis

  • 4.1 Overview
  • 4.2 Legal Requirements and Framework in Asia-Pacific
    • 4.2.1 China
    • 4.2.2 Japan
  • 4.3 Reimbursement Scenario
  • 4.4 Patent Analysis
    • 4.4.1 Patent Filing Trend (by Country)
    • 4.4.2 Patent Filing Trend (by Year)

5 Organ Transplant Diagnostics Market: Market Dynamics

  • 5.1 Impact Analysis
  • 5.2 Market Drivers
    • 5.2.1 Rise in Incidence of Chronic Diseases Leading to Organ Failure Increases the Use of Transplant Diagnostics
    • 5.2.2 Increase in Adoption of Stem Cell Therapy and Incidences of Leukemia Leading to an Upsurge in Demand for Transplant Diagnostics Tests
    • 5.2.3 Presence of Favorable Regulatory Scenarios including Reimbursement Schemes for Some Organ Transplant Diagnostics
    • 5.2.4 Advantages of Developing Advanced Molecular and Genomic Technologies in Transplant Diagnostics Tests
  • 5.3 Market Restraints
    • 5.3.1 Increased Gap in Organ Donation and Organ Transplant Demand Hinders the Growth of Organ Transplant Diagnostics Market
    • 5.3.2 High Cost of Investment for Transplant Diagnostics Tests Acts as a Barrier to Growth of the Market
  • 5.4 Market Opportunities
    • 5.4.1 Development of Non-Invasive Techniques for Monitoring Transplant Recipients using NGS
    • 5.4.2 Advancements in Human Leukocyte Antigen (HLA) Typing Tests for Organ Transplant

6 Region

  • 6.1 Asia-Pacific
    • 6.1.1 Asia-Pacific Organ Transplant Test Volume, by Transplant Type
    • 6.1.2 Market Sizing and Forecast
      • 6.1.2.1 Asia-Pacific Organ Transplant Diagnostics Market (by Country)
        • 6.1.2.1.1 China
        • 6.1.2.1.2 India
        • 6.1.2.1.3 South Korea
        • 6.1.2.1.4 Japan
        • 6.1.2.1.5 Australia
        • 6.1.2.1.6 Singapore
        • 6.1.2.1.7 Rest-of-Asia-Pacific

7 Company Profiles

  • 7.1 Overview
  • 7.2 Manufacturers

List of Figures

  • Figure 1: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
  • Figure 2: Organ Transplant Diagnostics Market, Impact Analysis
  • Figure 3: Asia-Pacific Organ Transplant Diagnostics Market (by Offering), Share (%), 2022 and 2033
  • Figure 4: Asia-Pacific Organ Transplant Diagnostics Market (by Transplant Type), Share (%), 2022 and 2033
  • Figure 5: Asia-Pacific Organ Transplant Diagnostics Market (by Application), Share (%), 2022 and 2033
  • Figure 6: Asia-Pacific Organ Transplant Diagnostics Market (by Technology), Share (%), 2022 and 2033
  • Figure 7: Asia-Pacific Organ Transplant Diagnostics Market (by End User), Share (%), 2022 and 2033
  • Figure 8: Organ Transplant Diagnostics Market: Research Methodology
  • Figure 9: Primary Research Methodology
  • Figure 10: Bottom-Up Approach (Segment-Wise Analysis)
  • Figure 11: Top-Down Approach (Segment-Wise Analysis)
  • Figure 12: Organ Transplant Diagnostics Market, $Billion, 2022-2033
  • Figure 13: Organ Transplant Diagnostics Market, Patent Analysis (by Country), January 2018-December 2022
  • Figure 14: Organ Transplant Diagnostics Market, Patent Analysis (by Year), January 2018-December 2022
  • Figure 15: Organ Transplant Diagnostics Market, Impact Analysis
  • Figure 16: New Liver Cirrhosis and Other Chronic Liver Diseases Cases, Thousand, 2017 and 2021
  • Figure 17: Number of Solid Organ Transplants, 2017-2021
  • Figure 18: Applications of Stem Cell Therapy
  • Figure 19: Number of Transplants Performed and Patients on the Waiting List (by Organ), 2022
  • Figure 20: Organ Transplant Diagnostics Market Share and CAGR (by Region), 2022 and 2023-2033
  • Figure 21: Asia-Pacific Organ Transplant Diagnostics Market, $Billion, 2022-2033
  • Figure 22: Asia-Pacific Organ Transplant Diagnostics Market (by Country), Share (%), 2022 and 2033
  • Figure 23: China Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 24: India Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 25: South Korea Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 26: Japan Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 27: Australia Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 28: Singapore Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 29: Rest-of-Asia-Pacific Organ Transplant Diagnostics Market, $Million, 2022-2033
  • Figure 30: Total Number of Companies Profiled
  • Figure 31: Organ Transplant Diagnostics Market Overview, Key Companies

List of Tables

  • Table 1: Key Questions Answered in the Report
  • Table 2: Key Coverage Providers for Organ Transplant Diagnostics Tests
  • Table 3: Asia-Pacific Organ Transplant Diagnostics Market, Impact Analysis
  • Table 4: Asia-Pacific Organ Transplant Test Volume, by Transplant Type, 2021